SCHEMBL20408342

SCHEMBL20408342

N#CCNS(=O)(=O)c1ccccc1[N+](=O)[O-]

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.60
CYP19A1 P11511 1/20 0.59
CA1 P00915 1/20 0.58
CA2 P00918 1/20 0.58
MMP1 P03956 1/20 0.58
MMP2 P08253 1/20 0.58
MMP9 P14780 1/20 0.58
MMP8 P22894 1/20 0.58
MMP13 P45452 1/20 0.58
LMNA P02545 1/20 0.57
KMT2A Q03164 3/20 0.56
MEN1 O00255 2/20 0.56
F2 P00734 3/20 0.54
PRSS1 P07477 3/20 0.54
PRSS2 P07478 3/20 0.54
PRSS3 P35030 3/20 0.54
THRB P10828 1/20 0.54
HTT P42858 1/20 0.50
CA12 O43570 1/20 0.50
GAA P10253 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2523913 0.85 ALDH1A1 (0.60) ALDH1A1CYP19A1CA1CA2MMP1
SCHEMBL30449135 0.85 ALDH1A1 (0.60) ALDH1A1CYP19A1CA1CA2MMP1
SCHEMBL29658814 0.83 ALDH1A1 (0.65) ALDH1A1CYP19A1CA1CA2MMP1
SCHEMBL2126962 0.83 ALDH1A1 (0.65) ALDH1A1CYP19A1CA1CA2MMP1
SCHEMBL4389696 0.82 KMT2A (0.71) ALDH1A1CYP19A1CA1CA2MMP1
SCHEMBL30649118 0.82 KMT2A (0.71) ALDH1A1CYP19A1CA1CA2MMP1
SCHEMBL13849424 0.80 ALDH1A1 (0.62) ALDH1A1CYP19A1CA1CA2MMP1
SCHEMBL2336131 0.80 KMT2A (0.64) ALDH1A1CYP19A1CA1CA2MMP1
SCHEMBL31284709 0.80 KMT2A (0.68) ALDH1A1CYP19A1CA1CA2MMP1
SCHEMBL29571128 0.80 KMT2A (0.68) ALDH1A1CYP19A1CA1CA2MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208588-A1 HETEROCYCLIC COMPOUNDS AND USE THEREOF NATIONAL HEALTH RES INST (TW) 2018-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180208588-A1 HETEROCYCLIC COMPOUNDS AND USE THEREOF CXCL12, HPGDS, CX3CR1 ALDH1A1 57/4885CYP19A1 356/4885CA1 3235/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.